Hospital costs of complications after a pancreatoduodenectomy

Abstract

This study provides an in-depth analysis of hospital costs and identifies factors that are associated with substantial cost consequences of specific complications occurring after a PD.

Health economic implications of complications associated with pancreaticoduodenectomy at a University Hospital: a retrospective cohort cost study

“…POPF increased costs more than threefold and hospitalisation length more than twofold over uncomplicated patients, agreeing with several cost studies of POPF. 7,16 Post pancreatectomy haemorrhage (PPH) was the costliest individual complication in our cohort, with an incidence of 9%. Our results correspond with Santema et al's 16 study, which found that PPH was costlier than POPF and DGE, with an incidence of 12%.…”

“…7,16 Post pancreatectomy haemorrhage (PPH) was the costliest individual complication in our cohort, with an incidence of 9%. Our results correspond with Santema et al's 16 study, which found that PPH was costlier than POPF and DGE, with an incidence of 12%. Considering the relative dearth of studies analysing the cost of PPH following PD compared to other complications such as POPF and DGE, future studies may aim to further clarify this important complication.…”

Disparities in the management and prophylaxis of surgical site infection and pancreatic fistula after pancreatoduodenectomy

“…Surgical site infections following PD vary from 7 to 32% , and contribute to increased length of hospital stay and re‐admissions . The presence of a postoperative SSI increases hospital costs by 32.4% after PD . The extra cost incurred is estimated at $15,336 per complication, with wound infection considered as the most common infectious complication .…”

“…The presence of a postoperative SSI increases hospital costs by 32.4% after PD . The extra cost incurred is estimated at $15,336 per complication, with wound infection considered as the most common infectious complication . More importantly, postoperative wound infection delays adjuvant chemotherapy in patients with pancreatic cancer and doubles the risk of chemotherapy omission .…”

“…Postoperative pancreatic fistula is the determinant morbidity factor after PD . The median total hospital costs for a patient with an anastomotic leakage are three times more than the costs of a patient without complications . Routine use of externalized intraperitoneal drains has traditionally been considered mandatory in major pancreatic resections.…”